Kura Oncology to Participate in Jefferies Global Healthcare Conference
May 29, 2024 07:30 ET
|
Kura Oncology, Inc.
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment...
AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
May 28, 2024 07:00 ET
|
AC Immune SA
AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024 Lausanne, Switzerland, May 28, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company...
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
May 16, 2024 08:00 ET
|
Fortress Biotech, Inc.
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...
Arbutus to Participate in Two Upcoming Investor Conferences
May 07, 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
March 28, 2024 08:00 ET
|
Arcutis Biotherapeutics, Inc.
Arcutis today announced that Arcutis management will participate in the 23rd Annual Needham Virtual Healthcare Conference, taking place April 8-11, 2024.
Arcutis to Present at the TD Cowen 44th Annual Health Care Conference
February 29, 2024 17:00 ET
|
Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in...
Kura Oncology to Participate in Three Upcoming Investor Conferences
February 22, 2024 07:30 ET
|
Kura Oncology, Inc.
SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Gevo VP of Government Relations Lindsay Fitzgerald and VP of Finance & Strategy Eric Frey to Participate in a Water Tower Research Fireside Chat on Tuesday, December 19th at 10:00 am ET
December 18, 2023 09:00 ET
|
Gevo, Inc.
ENGLEWOOD, Colo., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), announced today that Lindsay Fitzgerald, Vice President of Government Relations, and Eric Frey, Vice President of...
Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic
December 04, 2023 08:00 ET
|
Sagimet Biosciences Inc.
SAN MATEO, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN)...
AC Immune to Present at the Jefferies 2023 London Healthcare Conference
November 07, 2023 07:00 ET
|
AC Immune SA
AC Immune to Present at the Jefferies 2023 London Healthcare Conference Lausanne, Switzerland, November 7, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering...